The "Sarcopenia and Physical fRailty IN older people: multi-componenT Treatment strategies" (SPRINTT) randomized controlled trial: Case finding, screening and characteristics of eligible participants
- PMID: 30261246
- DOI: 10.1016/j.exger.2018.09.017
The "Sarcopenia and Physical fRailty IN older people: multi-componenT Treatment strategies" (SPRINTT) randomized controlled trial: Case finding, screening and characteristics of eligible participants
Abstract
Background: The ongoing "Sarcopenia and Physical fRailty IN older people: multi-componenT Treatment strategies (SPRINTT)" randomized controlled trial (RCT) is testing the efficacy of a multicomponent intervention in the prevention of mobility disability in older adults with physical frailty & sarcopenia (PF&S). Here, we describe the procedures followed for PF&S case finding and screening of candidate participants for the SPRINTT RCT. We also illustrate the main demographic and clinical characteristics of eligible screenees.
Methods: The identification of PF&S was based on the co-occurrence of three defining elements: (1) reduced physical performance (defined as a score on the Short Physical Performance Battery between 3 and 9); (2) low muscle mass according to the criteria released by the Foundation for the National Institutes of Health; and (3) absence of mobility disability (defined as ability to complete the 400-m walk test in 15 min). SPRINTT was advertised through a variety of means. Site-specific case finding strategies were developed to accommodate the variability across centers in catchment area characteristics and access to the target population. A quick "participant profiling" questionnaire was devised to facilitate PF&S case finding.
Results: During approximately 22 months, 12,358 prescreening interviews were completed in 17 SPRINTT sites resulting in 6710 clinic screening visits. Eventually, 1566 candidates were found to be eligible for participating in the SPRINTT RCT. Eligible screenees showed substantial physical function impairment and comorbidity burden. In most centers, project advertisement through mass media was the most rewarding case finding strategy.
Conclusion: PF&S case finding in the community is a challenging, but feasible task. Although largely autonomous in daily life activities, older adults with PF&S suffer from significant functional impairment and comorbidity. This subset of the older population is therefore at high risk for disability and other negative health-related events. Key strategies to consider for successfully intercepting at-risk older adults should focus on mass communication methods.
Keywords: Functional impairment; Mobility disability; Physical performance; Prevention; Recruitment; Skeletal muscle.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.
Similar articles
-
The "Sarcopenia and Physical fRailty IN older people: multi-componenT Treatment strategies" (SPRINTT) randomized controlled trial: design and methods.Aging Clin Exp Res. 2017 Feb;29(1):89-100. doi: 10.1007/s40520-016-0715-2. Epub 2017 Jan 31. Aging Clin Exp Res. 2017. PMID: 28144914 Clinical Trial.
-
Rationale for a preliminary operational definition of physical frailty and sarcopenia in the SPRINTT trial.Aging Clin Exp Res. 2017 Feb;29(1):81-88. doi: 10.1007/s40520-016-0716-1. Epub 2017 Feb 10. Aging Clin Exp Res. 2017. PMID: 28188558
-
The sarcopenia and physical frailty in older people: multi-component treatment strategies (SPRINTT) project: description and feasibility of a nutrition intervention in community-dwelling older Europeans.Eur Geriatr Med. 2021 Apr;12(2):303-312. doi: 10.1007/s41999-020-00438-4. Epub 2021 Feb 13. Eur Geriatr Med. 2021. PMID: 33583000 Free PMC article. Clinical Trial.
-
Physical frailty and sarcopenia (PF&S): a point of view from the industry.Aging Clin Exp Res. 2017 Feb;29(1):69-74. doi: 10.1007/s40520-016-0710-7. Epub 2017 Feb 3. Aging Clin Exp Res. 2017. PMID: 28160253 Review.
-
Sarcopenia: an overview.Aging Clin Exp Res. 2017 Feb;29(1):11-17. doi: 10.1007/s40520-016-0704-5. Epub 2017 Feb 2. Aging Clin Exp Res. 2017. PMID: 28155183 Review.
Cited by
-
Evaluation of serum miRNAs expression in frail and robust subjects undergoing multicomponent exercise protocol (VIVIFRAIL).J Transl Med. 2023 Feb 2;21(1):67. doi: 10.1186/s12967-023-03911-3. J Transl Med. 2023. PMID: 36726153 Free PMC article.
-
Challenges in the Development of Drugs for Sarcopenia and Frailty - Report from the International Conference on Frailty and Sarcopenia Research (ICFSR) Task Force.J Frailty Aging. 2022;11(2):135-142. doi: 10.14283/jfa.2022.30. J Frailty Aging. 2022. PMID: 35441189 Free PMC article.
-
Preventing autonomy loss with multicomponent geriatric interventions: A resource-saving strategy? Evidence from the SPRINT-T study.SSM Popul Health. 2023 Oct 5;24:101507. doi: 10.1016/j.ssmph.2023.101507. eCollection 2023 Dec. SSM Popul Health. 2023. PMID: 37860705 Free PMC article.
-
The "develOpment of metabolic and functional markers of Dementia IN Older people" (ODINO) Study: Rationale, Design and Methods.J Pers Med. 2020 Apr 9;10(2):22. doi: 10.3390/jpm10020022. J Pers Med. 2020. PMID: 32283734 Free PMC article.
-
Evidence-based recommendations for resistance and power training to prevent frailty in community-dwellers.Aging Clin Exp Res. 2021 Aug;33(8):2069-2086. doi: 10.1007/s40520-021-01802-5. Epub 2021 Feb 15. Aging Clin Exp Res. 2021. PMID: 33587271 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical